nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—CYP2C8—Fluorouracil—head and neck cancer	0.235	0.353	CbGbCtD
Sitagliptin—ABCB1—Vinblastine—head and neck cancer	0.148	0.222	CbGbCtD
Sitagliptin—ABCB1—Docetaxel—head and neck cancer	0.122	0.183	CbGbCtD
Sitagliptin—CYP3A4—Vinblastine—head and neck cancer	0.0884	0.133	CbGbCtD
Sitagliptin—CYP3A4—Docetaxel—head and neck cancer	0.0729	0.109	CbGbCtD
Sitagliptin—Non-cardiac chest pain—Docetaxel—head and neck cancer	0.0178	0.0572	CcSEcCtD
Sitagliptin—Cellulitis—Vinblastine—head and neck cancer	0.00719	0.023	CcSEcCtD
Sitagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—GRP—head and neck cancer	0.00512	0.235	CbGpPWpGaD
Sitagliptin—Parosmia—Docetaxel—head and neck cancer	0.00477	0.0153	CcSEcCtD
Sitagliptin—Cellulitis—Fluorouracil—head and neck cancer	0.00472	0.0151	CcSEcCtD
Sitagliptin—Renal failure acute—Hydroxyurea—head and neck cancer	0.00469	0.015	CcSEcCtD
Sitagliptin—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.00459	0.0147	CcSEcCtD
Sitagliptin—DPP4—Incretin synthesis, secretion, and inactivation—GRP—head and neck cancer	0.00455	0.209	CbGpPWpGaD
Sitagliptin—Laryngeal pain—Docetaxel—head and neck cancer	0.00454	0.0145	CcSEcCtD
Sitagliptin—Face oedema—Hydroxyurea—head and neck cancer	0.00418	0.0134	CcSEcCtD
Sitagliptin—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00405	0.013	CcSEcCtD
Sitagliptin—Breast disorder—Hydroxyurea—head and neck cancer	0.00391	0.0125	CcSEcCtD
Sitagliptin—Pancreatitis—Hydroxyurea—head and neck cancer	0.00367	0.0117	CcSEcCtD
Sitagliptin—Depression—Vinblastine—head and neck cancer	0.00364	0.0117	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00358	0.0115	CcSEcCtD
Sitagliptin—Weight increased—Hydroxyurea—head and neck cancer	0.0034	0.0109	CcSEcCtD
Sitagliptin—Infestation—Hydroxyurea—head and neck cancer	0.00333	0.0107	CcSEcCtD
Sitagliptin—Infestation NOS—Hydroxyurea—head and neck cancer	0.00333	0.0107	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00327	0.0105	CcSEcCtD
Sitagliptin—Hypoaesthesia—Vinblastine—head and neck cancer	0.00326	0.0105	CcSEcCtD
Sitagliptin—Pharyngitis—Vinblastine—head and neck cancer	0.00326	0.0104	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00315	0.0101	CcSEcCtD
Sitagliptin—Osteoarthritis—Fluorouracil—head and neck cancer	0.00311	0.00997	CcSEcCtD
Sitagliptin—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00278	0.00892	CcSEcCtD
Sitagliptin—Angiopathy—Hydroxyurea—head and neck cancer	0.00272	0.0087	CcSEcCtD
Sitagliptin—Ill-defined disorder—Vinblastine—head and neck cancer	0.00265	0.00849	CcSEcCtD
Sitagliptin—Malaise—Vinblastine—head and neck cancer	0.00258	0.00825	CcSEcCtD
Sitagliptin—Vertigo—Vinblastine—head and neck cancer	0.00257	0.00822	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.0025	0.00801	CcSEcCtD
Sitagliptin—Hypertension—Vinblastine—head and neck cancer	0.00247	0.0079	CcSEcCtD
Sitagliptin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00242	0.00774	CcSEcCtD
Sitagliptin—Pneumonia—Fluorouracil—head and neck cancer	0.00241	0.00773	CcSEcCtD
Sitagliptin—Discomfort—Vinblastine—head and neck cancer	0.0024	0.0077	CcSEcCtD
Sitagliptin—Infestation NOS—Fluorouracil—head and neck cancer	0.0024	0.00769	CcSEcCtD
Sitagliptin—Infestation—Fluorouracil—head and neck cancer	0.0024	0.00769	CcSEcCtD
Sitagliptin—Renal impairment—Docetaxel—head and neck cancer	0.00236	0.00756	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00235	0.00753	CcSEcCtD
Sitagliptin—Malaise—Hydroxyurea—head and neck cancer	0.00235	0.00752	CcSEcCtD
Sitagliptin—Urinary tract infection—Fluorouracil—head and neck cancer	0.00233	0.00747	CcSEcCtD
Sitagliptin—Sinusitis—Fluorouracil—head and neck cancer	0.00225	0.00721	CcSEcCtD
Sitagliptin—Pain in extremity—Docetaxel—head and neck cancer	0.00225	0.0072	CcSEcCtD
Sitagliptin—Migraine—Docetaxel—head and neck cancer	0.00221	0.00709	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.0022	0.00705	CcSEcCtD
Sitagliptin—Discomfort—Hydroxyurea—head and neck cancer	0.00219	0.00702	CcSEcCtD
Sitagliptin—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00214	0.00686	CcSEcCtD
Sitagliptin—Pharyngitis—Fluorouracil—head and neck cancer	0.00214	0.00685	CcSEcCtD
Sitagliptin—Infection—Hydroxyurea—head and neck cancer	0.00211	0.00677	CcSEcCtD
Sitagliptin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00208	0.00668	CcSEcCtD
Sitagliptin—Skin disorder—Hydroxyurea—head and neck cancer	0.00207	0.00661	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00205	0.00657	CcSEcCtD
Sitagliptin—Abdominal pain upper—Docetaxel—head and neck cancer	0.00205	0.00657	CcSEcCtD
Sitagliptin—Breast disorder—Docetaxel—head and neck cancer	0.00203	0.0065	CcSEcCtD
Sitagliptin—Decreased appetite—Vinblastine—head and neck cancer	0.00203	0.00649	CcSEcCtD
Sitagliptin—Nasopharyngitis—Docetaxel—head and neck cancer	0.00201	0.00644	CcSEcCtD
Sitagliptin—Pain—Vinblastine—head and neck cancer	0.00199	0.00639	CcSEcCtD
Sitagliptin—Constipation—Vinblastine—head and neck cancer	0.00199	0.00639	CcSEcCtD
Sitagliptin—Feeling abnormal—Vinblastine—head and neck cancer	0.00192	0.00615	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00191	0.00611	CcSEcCtD
Sitagliptin—Somnolence—Hydroxyurea—head and neck cancer	0.00189	0.00605	CcSEcCtD
Sitagliptin—Dyspepsia—Hydroxyurea—head and neck cancer	0.00187	0.00599	CcSEcCtD
Sitagliptin—Decreased appetite—Hydroxyurea—head and neck cancer	0.00185	0.00592	CcSEcCtD
Sitagliptin—Abdominal pain—Vinblastine—head and neck cancer	0.00184	0.0059	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00184	0.00588	CcSEcCtD
Sitagliptin—Fatigue—Hydroxyurea—head and neck cancer	0.00183	0.00587	CcSEcCtD
Sitagliptin—Pain—Hydroxyurea—head and neck cancer	0.00182	0.00582	CcSEcCtD
Sitagliptin—Constipation—Hydroxyurea—head and neck cancer	0.00182	0.00582	CcSEcCtD
Sitagliptin—Weight increased—Docetaxel—head and neck cancer	0.00177	0.00566	CcSEcCtD
Sitagliptin—Vision blurred—Fluorouracil—head and neck cancer	0.00177	0.00566	CcSEcCtD
Sitagliptin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00175	0.00561	CcSEcCtD
Sitagliptin—Pneumonia—Docetaxel—head and neck cancer	0.00174	0.00558	CcSEcCtD
Sitagliptin—Infestation NOS—Docetaxel—head and neck cancer	0.00173	0.00555	CcSEcCtD
Sitagliptin—Infestation—Docetaxel—head and neck cancer	0.00173	0.00555	CcSEcCtD
Sitagliptin—Hypersensitivity—Vinblastine—head and neck cancer	0.00172	0.0055	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00172	0.0055	CcSEcCtD
Sitagliptin—Renal failure—Docetaxel—head and neck cancer	0.0017	0.00545	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Docetaxel—head and neck cancer	0.0017	0.00544	CcSEcCtD
Sitagliptin—Asthenia—Vinblastine—head and neck cancer	0.00167	0.00536	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00164	0.00525	CcSEcCtD
Sitagliptin—Myalgia—Fluorouracil—head and neck cancer	0.0016	0.00511	CcSEcCtD
Sitagliptin—Diarrhoea—Vinblastine—head and neck cancer	0.0016	0.00511	CcSEcCtD
Sitagliptin—Discomfort—Fluorouracil—head and neck cancer	0.00158	0.00505	CcSEcCtD
Sitagliptin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00157	0.00502	CcSEcCtD
Sitagliptin—Hypoaesthesia—Docetaxel—head and neck cancer	0.00155	0.00495	CcSEcCtD
Sitagliptin—DPP4—Peptide hormone metabolism—GRP—head and neck cancer	0.00154	0.071	CbGpPWpGaD
Sitagliptin—Pharyngitis—Docetaxel—head and neck cancer	0.00154	0.00494	CcSEcCtD
Sitagliptin—Dizziness—Vinblastine—head and neck cancer	0.00154	0.00494	CcSEcCtD
Sitagliptin—Urinary tract disorder—Docetaxel—head and neck cancer	0.00154	0.00492	CcSEcCtD
Sitagliptin—Oedema peripheral—Docetaxel—head and neck cancer	0.00153	0.00491	CcSEcCtD
Sitagliptin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00153	0.0049	CcSEcCtD
Sitagliptin—Connective tissue disorder—Docetaxel—head and neck cancer	0.00153	0.00489	CcSEcCtD
Sitagliptin—Asthenia—Hydroxyurea—head and neck cancer	0.00153	0.00489	CcSEcCtD
Sitagliptin—Urethral disorder—Docetaxel—head and neck cancer	0.00152	0.00488	CcSEcCtD
Sitagliptin—Infection—Fluorouracil—head and neck cancer	0.00152	0.00487	CcSEcCtD
Sitagliptin—Nervous system disorder—Fluorouracil—head and neck cancer	0.0015	0.00481	CcSEcCtD
Sitagliptin—Vomiting—Vinblastine—head and neck cancer	0.00148	0.00475	CcSEcCtD
Sitagliptin—Erythema multiforme—Docetaxel—head and neck cancer	0.00147	0.00471	CcSEcCtD
Sitagliptin—Headache—Vinblastine—head and neck cancer	0.00146	0.00468	CcSEcCtD
Sitagliptin—Diarrhoea—Hydroxyurea—head and neck cancer	0.00145	0.00466	CcSEcCtD
Sitagliptin—Eye disorder—Docetaxel—head and neck cancer	0.00145	0.00465	CcSEcCtD
Sitagliptin—Cardiac disorder—Docetaxel—head and neck cancer	0.00144	0.00462	CcSEcCtD
Sitagliptin—Angiopathy—Docetaxel—head and neck cancer	0.00141	0.00452	CcSEcCtD
Sitagliptin—Dizziness—Hydroxyurea—head and neck cancer	0.00141	0.0045	CcSEcCtD
Sitagliptin—Immune system disorder—Docetaxel—head and neck cancer	0.0014	0.0045	CcSEcCtD
Sitagliptin—Mediastinal disorder—Docetaxel—head and neck cancer	0.0014	0.00449	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00139	0.00447	CcSEcCtD
Sitagliptin—Nausea—Vinblastine—head and neck cancer	0.00138	0.00444	CcSEcCtD
Sitagliptin—Insomnia—Fluorouracil—head and neck cancer	0.00138	0.00443	CcSEcCtD
Sitagliptin—Mental disorder—Docetaxel—head and neck cancer	0.00136	0.00436	CcSEcCtD
Sitagliptin—Somnolence—Fluorouracil—head and neck cancer	0.00136	0.00436	CcSEcCtD
Sitagliptin—Malnutrition—Docetaxel—head and neck cancer	0.00135	0.00433	CcSEcCtD
Sitagliptin—Vomiting—Hydroxyurea—head and neck cancer	0.00135	0.00433	CcSEcCtD
Sitagliptin—Dyspepsia—Fluorouracil—head and neck cancer	0.00135	0.00431	CcSEcCtD
Sitagliptin—Rash—Hydroxyurea—head and neck cancer	0.00134	0.00429	CcSEcCtD
Sitagliptin—Dermatitis—Hydroxyurea—head and neck cancer	0.00134	0.00429	CcSEcCtD
Sitagliptin—Headache—Hydroxyurea—head and neck cancer	0.00133	0.00427	CcSEcCtD
Sitagliptin—Decreased appetite—Fluorouracil—head and neck cancer	0.00133	0.00426	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00132	0.00423	CcSEcCtD
Sitagliptin—Back pain—Docetaxel—head and neck cancer	0.00131	0.00419	CcSEcCtD
Sitagliptin—Pain—Fluorouracil—head and neck cancer	0.00131	0.00419	CcSEcCtD
Sitagliptin—Muscle spasms—Docetaxel—head and neck cancer	0.0013	0.00417	CcSEcCtD
Sitagliptin—Nausea—Hydroxyurea—head and neck cancer	0.00126	0.00404	CcSEcCtD
Sitagliptin—Feeling abnormal—Fluorouracil—head and neck cancer	0.00126	0.00404	CcSEcCtD
Sitagliptin—Urticaria—Fluorouracil—head and neck cancer	0.00122	0.00389	CcSEcCtD
Sitagliptin—Cough—Docetaxel—head and neck cancer	0.00118	0.00378	CcSEcCtD
Sitagliptin—Hypertension—Docetaxel—head and neck cancer	0.00117	0.00374	CcSEcCtD
Sitagliptin—Arthralgia—Docetaxel—head and neck cancer	0.00115	0.00369	CcSEcCtD
Sitagliptin—Myalgia—Docetaxel—head and neck cancer	0.00115	0.00369	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00114	0.00367	CcSEcCtD
Sitagliptin—Hypersensitivity—Fluorouracil—head and neck cancer	0.00113	0.00361	CcSEcCtD
Sitagliptin—Dry mouth—Docetaxel—head and neck cancer	0.00113	0.00361	CcSEcCtD
Sitagliptin—Anaphylactic shock—Docetaxel—head and neck cancer	0.0011	0.00354	CcSEcCtD
Sitagliptin—Infection—Docetaxel—head and neck cancer	0.0011	0.00351	CcSEcCtD
Sitagliptin—Nervous system disorder—Docetaxel—head and neck cancer	0.00108	0.00347	CcSEcCtD
Sitagliptin—Skin disorder—Docetaxel—head and neck cancer	0.00107	0.00344	CcSEcCtD
Sitagliptin—Diarrhoea—Fluorouracil—head and neck cancer	0.00105	0.00335	CcSEcCtD
Sitagliptin—Dizziness—Fluorouracil—head and neck cancer	0.00101	0.00324	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00101	0.00322	CcSEcCtD
Sitagliptin—Insomnia—Docetaxel—head and neck cancer	0.000999	0.0032	CcSEcCtD
Sitagliptin—Somnolence—Docetaxel—head and neck cancer	0.000982	0.00315	CcSEcCtD
Sitagliptin—Vomiting—Fluorouracil—head and neck cancer	0.000973	0.00312	CcSEcCtD
Sitagliptin—Dyspepsia—Docetaxel—head and neck cancer	0.000972	0.00311	CcSEcCtD
Sitagliptin—Rash—Fluorouracil—head and neck cancer	0.000965	0.00309	CcSEcCtD
Sitagliptin—Dermatitis—Fluorouracil—head and neck cancer	0.000964	0.00309	CcSEcCtD
Sitagliptin—Decreased appetite—Docetaxel—head and neck cancer	0.00096	0.00308	CcSEcCtD
Sitagliptin—Headache—Fluorouracil—head and neck cancer	0.000959	0.00307	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000954	0.00305	CcSEcCtD
Sitagliptin—Fatigue—Docetaxel—head and neck cancer	0.000952	0.00305	CcSEcCtD
Sitagliptin—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000945	0.0434	CbGpPWpGaD
Sitagliptin—Pain—Docetaxel—head and neck cancer	0.000945	0.00303	CcSEcCtD
Sitagliptin—Constipation—Docetaxel—head and neck cancer	0.000945	0.00303	CcSEcCtD
Sitagliptin—Feeling abnormal—Docetaxel—head and neck cancer	0.00091	0.00292	CcSEcCtD
Sitagliptin—Nausea—Fluorouracil—head and neck cancer	0.000909	0.00291	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000903	0.00289	CcSEcCtD
Sitagliptin—Abdominal pain—Docetaxel—head and neck cancer	0.000873	0.0028	CcSEcCtD
Sitagliptin—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00086	0.0395	CbGpPWpGaD
Sitagliptin—Hypersensitivity—Docetaxel—head and neck cancer	0.000814	0.00261	CcSEcCtD
Sitagliptin—Asthenia—Docetaxel—head and neck cancer	0.000792	0.00254	CcSEcCtD
Sitagliptin—Diarrhoea—Docetaxel—head and neck cancer	0.000756	0.00242	CcSEcCtD
Sitagliptin—Dizziness—Docetaxel—head and neck cancer	0.00073	0.00234	CcSEcCtD
Sitagliptin—Vomiting—Docetaxel—head and neck cancer	0.000702	0.00225	CcSEcCtD
Sitagliptin—Rash—Docetaxel—head and neck cancer	0.000696	0.00223	CcSEcCtD
Sitagliptin—Dermatitis—Docetaxel—head and neck cancer	0.000696	0.00223	CcSEcCtD
Sitagliptin—Headache—Docetaxel—head and neck cancer	0.000692	0.00222	CcSEcCtD
Sitagliptin—Nausea—Docetaxel—head and neck cancer	0.000656	0.0021	CcSEcCtD
Sitagliptin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000595	0.0274	CbGpPWpGaD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000505	0.0232	CbGpPWpGaD
Sitagliptin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000461	0.0212	CbGpPWpGaD
Sitagliptin—CYP2C8—Xenobiotics—CYP1A1—head and neck cancer	0.000454	0.0209	CbGpPWpGaD
Sitagliptin—CYP2C8—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000436	0.0201	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000311	0.0143	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—GRP—head and neck cancer	0.000291	0.0134	CbGpPWpGaD
Sitagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000291	0.0134	CbGpPWpGaD
Sitagliptin—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00028	0.0128	CbGpPWpGaD
Sitagliptin—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000265	0.0122	CbGpPWpGaD
Sitagliptin—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000244	0.0112	CbGpPWpGaD
Sitagliptin—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000234	0.0108	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00022	0.0101	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000218	0.01	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000188	0.00866	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000186	0.00855	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000173	0.00797	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000171	0.00786	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000153	0.00702	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00013	0.00596	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000127	0.00584	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000125	0.00575	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000116	0.00531	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000101	0.00465	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	9.98e-05	0.00459	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CASP8—head and neck cancer	9.61e-05	0.00442	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—NAT2—head and neck cancer	9.3e-05	0.00428	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	9.18e-05	0.00422	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	8.56e-05	0.00393	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	8.44e-05	0.00388	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	8.2e-05	0.00377	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	8.12e-05	0.00373	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	8e-05	0.00368	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL2—head and neck cancer	7.26e-05	0.00334	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—UROD—head and neck cancer	7.14e-05	0.00328	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	7.13e-05	0.00328	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	6.98e-05	0.00321	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	6.94e-05	0.00319	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—UROD—head and neck cancer	6.22e-05	0.00286	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	6.17e-05	0.00284	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.54e-05	0.00255	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	4.74e-05	0.00218	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	4.6e-05	0.00211	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	4.55e-05	0.00209	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	4.53e-05	0.00208	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	4.36e-05	0.002	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	4.3e-05	0.00197	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	4.07e-05	0.00187	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	3.87e-05	0.00178	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—UROD—head and neck cancer	3.83e-05	0.00176	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	3.49e-05	0.00161	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.37e-05	0.00155	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.15e-05	0.00145	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.12e-05	0.00143	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.05e-05	0.0014	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NAT2—head and neck cancer	2.96e-05	0.00136	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.88e-05	0.00132	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.74e-05	0.00126	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.74e-05	0.00126	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—DPYD—head and neck cancer	2.6e-05	0.00119	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NAT2—head and neck cancer	2.58e-05	0.00119	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—YAP1—head and neck cancer	2.47e-05	0.00113	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.38e-05	0.00109	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.3e-05	0.00106	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—DPYD—head and neck cancer	2.26e-05	0.00104	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—YAP1—head and neck cancer	2.15e-05	0.000988	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.94e-05	0.000893	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.85e-05	0.000852	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.62e-05	0.000743	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NAT2—head and neck cancer	1.59e-05	0.000731	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—TYMS—head and neck cancer	1.48e-05	0.000681	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.46e-05	0.000673	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GPX1—head and neck cancer	1.4e-05	0.000644	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—DPYD—head and neck cancer	1.4e-05	0.000641	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.39e-05	0.000638	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—YAP1—head and neck cancer	1.32e-05	0.000608	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—TYMS—head and neck cancer	1.29e-05	0.000593	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTM1—head and neck cancer	1.28e-05	0.000586	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GPX1—head and neck cancer	1.22e-05	0.000561	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.21e-05	0.000556	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.14e-05	0.000524	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTGS2—head and neck cancer	8.25e-06	0.000379	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—TYMS—head and neck cancer	7.95e-06	0.000365	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTM1—head and neck cancer	7.86e-06	0.000361	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GPX1—head and neck cancer	7.53e-06	0.000346	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP1A1—head and neck cancer	7.45e-06	0.000342	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTEN—head and neck cancer	7.2e-06	0.000331	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTGS2—head and neck cancer	7.19e-06	0.00033	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTEN—head and neck cancer	6.27e-06	0.000288	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CA—head and neck cancer	5.08e-06	0.000233	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTGS2—head and neck cancer	4.43e-06	0.000204	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CA—head and neck cancer	4.42e-06	0.000203	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—AKT1—head and neck cancer	4.15e-06	0.000191	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTEN—head and neck cancer	3.86e-06	0.000178	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—AKT1—head and neck cancer	3.61e-06	0.000166	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.73e-06	0.000125	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—AKT1—head and neck cancer	2.23e-06	0.000102	CbGpPWpGaD
